Diabetic macular edema: new trends in management

The treatment of diabetic macular edema may be evolving from a laser ablative approach into a pharmacotherapeutic approach. The exponential growth that has occurred over the past decade in the retinal pharmacotherapy field has led to the development of several pharmacotherapies for retinal vascular...

Full description

Saved in:
Bibliographic Details
Main Author: Al Shamsi, Hanin (author)
Other Authors: Ghazi, Nicola G. (author)
Format: article
Published: 2012
Online Access:http://hdl.handle.net/10725/10826
https://doi.org/10.1586/ecp.11.67
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.tandfonline.com/doi/full/10.1586/ecp.11.67
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513467495481344
author Al Shamsi, Hanin
author2 Ghazi, Nicola G.
author2_role author
author_facet Al Shamsi, Hanin
Ghazi, Nicola G.
author_role author
dc.creator.none.fl_str_mv Al Shamsi, Hanin
Ghazi, Nicola G.
dc.date.none.fl_str_mv 2012
2019-06-14T10:38:56Z
2019-06-14T10:38:56Z
2019-06-14
dc.identifier.none.fl_str_mv 1751-244
http://hdl.handle.net/10725/10826
https://doi.org/10.1586/ecp.11.67
Shamsi, H. A., & Ghazi, N. G. (2012). Diabetic macular edema: new trends in management. Expert review of clinical pharmacology, 5(1), 55-68.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.tandfonline.com/doi/full/10.1586/ecp.11.67
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Expert review of Clinical Pharmacology
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Diabetic macular edema: new trends in management
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description The treatment of diabetic macular edema may be evolving from a laser ablative approach into a pharmacotherapeutic approach. The exponential growth that has occurred over the past decade in the retinal pharmacotherapy field has led to the development of several pharmacotherapies for retinal vascular diseases such as diabetic macular edema. Many of these agents, in the form of intravitreal injections or sustained delivery devices, have already undergone clinical trial testing for safety and efficacy and many others are currently being similarly evaluated. Some of these agents have proven to be more efficacious than traditional laser therapy, and it is possible that traditional laser therapy for diabetic macular edema may be abandoned altogether in the near future, especially with the introduction of the micropulse laser. However, more research and experience is still needed in order to determine the best treatment agent or combination of therapeutic modalities, as well as the best treatment regimen for a given patient. In this article, we briefly review the major new developments in the field of diabetic macular edema treatment. In addition, we touch on some of the promising forthcoming therapies
eu_rights_str_mv openAccess
format article
id LAURepo_8d367e2ff183273d3b93d2e4e1e950d4
identifier_str_mv 1751-244
Shamsi, H. A., & Ghazi, N. G. (2012). Diabetic macular edema: new trends in management. Expert review of clinical pharmacology, 5(1), 55-68.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/10826
publishDate 2012
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Diabetic macular edema: new trends in managementAl Shamsi, HaninGhazi, Nicola G.The treatment of diabetic macular edema may be evolving from a laser ablative approach into a pharmacotherapeutic approach. The exponential growth that has occurred over the past decade in the retinal pharmacotherapy field has led to the development of several pharmacotherapies for retinal vascular diseases such as diabetic macular edema. Many of these agents, in the form of intravitreal injections or sustained delivery devices, have already undergone clinical trial testing for safety and efficacy and many others are currently being similarly evaluated. Some of these agents have proven to be more efficacious than traditional laser therapy, and it is possible that traditional laser therapy for diabetic macular edema may be abandoned altogether in the near future, especially with the introduction of the micropulse laser. However, more research and experience is still needed in order to determine the best treatment agent or combination of therapeutic modalities, as well as the best treatment regimen for a given patient. In this article, we briefly review the major new developments in the field of diabetic macular edema treatment. In addition, we touch on some of the promising forthcoming therapiesPublishedN/A2019-06-14T10:38:56Z2019-06-14T10:38:56Z20122019-06-14Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1751-244http://hdl.handle.net/10725/10826https://doi.org/10.1586/ecp.11.67Shamsi, H. A., & Ghazi, N. G. (2012). Diabetic macular edema: new trends in management. Expert review of clinical pharmacology, 5(1), 55-68.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://www.tandfonline.com/doi/full/10.1586/ecp.11.67enExpert review of Clinical Pharmacologyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/108262021-03-19T10:45:17Z
spellingShingle Diabetic macular edema: new trends in management
Al Shamsi, Hanin
status_str publishedVersion
title Diabetic macular edema: new trends in management
title_full Diabetic macular edema: new trends in management
title_fullStr Diabetic macular edema: new trends in management
title_full_unstemmed Diabetic macular edema: new trends in management
title_short Diabetic macular edema: new trends in management
title_sort Diabetic macular edema: new trends in management
url http://hdl.handle.net/10725/10826
https://doi.org/10.1586/ecp.11.67
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.tandfonline.com/doi/full/10.1586/ecp.11.67